메뉴 건너뛰기




Volumn 120, Issue 2, 2012, Pages 244-246

Pretransplant MRD: The light is yellow, not red

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER PROGNOSIS; FLOW CYTOMETRY; HUMAN; MINIMAL RESIDUAL DISEASE; NOTE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 84864131600     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-05-427443     Document Type: Note
Times cited : (8)

References (12)
  • 1
    • 84864047454 scopus 로고    scopus 로고
    • Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
    • Leung W, Pui C-H, Coustan-Smith E, et al. Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood. 2012;120(2):468-472.
    • (2012) Blood , vol.120 , Issue.2 , pp. 468-472
    • Leung, W.1    Pui, C.-H.2    Coustan-Smith, E.3
  • 2
    • 77955503223 scopus 로고    scopus 로고
    • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes
    • Erratum in: Biol Blood Marrow Transplant. 2010;16(12):1752
    • Kröger N, Bacher U, Bader P, et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2010;16(9):1187-1211. Erratum in: Biol Blood Marrow Transplant. 2010;16(12):1752.
    • (2010) Biol Blood Marrow Transplant , vol.16 , Issue.9 , pp. 1187-1211
    • Kröger, N.1    Bacher, U.2    Bader, P.3
  • 3
    • 77956309607 scopus 로고    scopus 로고
    • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part II: Chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
    • Kröger N, Bacher U, Bader P, et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part II: Chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant. 2010;16(10):1325-1346.
    • (2010) Biol Blood Marrow Transplant , vol.16 , Issue.10 , pp. 1325-1346
    • Kröger, N.1    Bacher, U.2    Bader, P.3
  • 5
    • 58549091682 scopus 로고    scopus 로고
    • Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: The ALL-REZBFM Study Group
    • Bader P, Kreyenberg H, Henze GH, et al. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZBFM Study Group. J Clin Oncol. 2009;27(3):377-384.
    • (2009) J Clin Oncol , vol.27 , Issue.3 , pp. 377-384
    • Bader, P.1    Kreyenberg, H.2    Henze, G.H.3
  • 6
    • 0242367154 scopus 로고    scopus 로고
    • Predictors of relapse and overall survival in Philadelphia chromosomepositive acute lymphoblastic leukemia after transplantation
    • Stirewalt DL, Guthrie KA, Beppu L, et al. Predictors of relapse and overall survival in Philadelphia chromosomepositive acute lymphoblastic leukemia after transplantation. Biol Blood Marrow Transplant. 2003;9(3):206-212.
    • (2003) Biol Blood Marrow Transplant , vol.9 , Issue.3 , pp. 206-212
    • Stirewalt, D.L.1    Guthrie, K.A.2    Beppu, L.3
  • 8
    • 79952757082 scopus 로고    scopus 로고
    • Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia
    • Walter RB, Gooley TA, Wood BL, et al. Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia. J Clin Oncol. 2011;29(9):1190-1197.
    • (2011) J Clin Oncol , vol.29 , Issue.9 , pp. 1190-1197
    • Walter, R.B.1    Gooley, T.A.2    Wood, B.L.3
  • 9
    • 78649429727 scopus 로고    scopus 로고
    • Reduced mortality after allogeneic hematopoietic-cell transplantation
    • Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. New Engl J Med. 2010;363(22):2091-2101.
    • (2010) New Engl J Med , vol.363 , Issue.22 , pp. 2091-2101
    • Gooley, T.A.1    Chien, J.W.2    Pergam, S.A.3
  • 10
    • 79952609273 scopus 로고    scopus 로고
    • National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee
    • Bishop MR, Alyea EP III, Cairo MS, et al. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee. Biol Blood Marrow Transplant. 2011;17(4):443-454.
    • (2011) Biol Blood Marrow Transplant , vol.17 , Issue.4 , pp. 443-454
    • Bishop, M.R.1    Alyea III, E.P.2    Cairo, M.S.3
  • 11
    • 84861120541 scopus 로고    scopus 로고
    • Highthroughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia
    • Wu D, Sherwood A, Fromm JR, et al. Highthroughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. Sci Transl Med. 2012;4(134):134ra63.
    • (2012) Sci Transl Med , vol.4 , Issue.134
    • Wu, D.1    Sherwood, A.2    Fromm, J.R.3
  • 12
    • 79959450187 scopus 로고    scopus 로고
    • New markers for minimal residual disease detection in acute lymphoblastic leukemia
    • Coustan-Smith E, Song G, Clark C, et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2011;117(23):6267- 6276.
    • (2011) Blood , vol.117 , Issue.23 , pp. 6267-6276
    • Coustan-Smith, E.1    Song, G.2    Clark, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.